Tardugno Michael H's Form 4 filing
Imunon, Inc.IMNN · filed Apr 12, 2022
- Accession no.
- 0001437749-22-008740
- Filed
- Apr 12, 2022
- Trade date
- Apr 12, 2022
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market purchases total $14.1K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Tardugno Michael HCIK 0001384550 | Director, Officer (Chairman, President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 12, 2022 | Celsion Corporation Common Stock | PPurchaseAcquired | +4,000 | $3.53 | +$14,120 | 16,513 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.